BeStock  
Stocks › Biotechnology › DYN

Dyne Therapeutics DYN

US equityMarket cap rank #2457Biotechnology
$15.50 −$0.53 (-3.31%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.50 0.00%
Open$15.91
Prev close$16.03
Day range$15.41 – $16.48
Volume2.23M
Market cap$2.90B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$34.90+125.2% vs. price
  • Buy 90%
  • Sell 10%
Low $10.00Now $15.50Avg $34.90High $50.00

Recent rating changes

The last 20 actions on file set price targets from $10.00 to $50.00, averaging $36.50.

DateFirmRatingTarget
11 Nov 2026 Raymond James BUY $41.00
6 Nov 2026 Morgan Stanley BUY $36.00
6 Nov 2026 H.C. Wainwright BUY $32.00
5 Nov 2026 RBC Capital BUY $30.00
30 Sep 2026 LifeSci Capital BUY $40.00
30 Sep 2026 Stifel BUY $37.00
30 Sep 2026 H.C. Wainwright BUY $32.00
29 Sep 2026 Piper Sandler BUY $47.00
23 Sep 2026 Raymond James BUY $37.00
9 Sep 2026 Baird BUY $26.00
9 Sep 2026 Morgan Stanley BUY $36.00
8 Sep 2026 LifeSci Capital BUY $40.00
8 Sep 2026 Jefferies BUY $50.00
8 Sep 2026 Stifel BUY $37.00
8 Sep 2026 RBC Capital BUY $30.00
8 Sep 2026 J.P. Morgan SELL $10.00
25 Aug 2026 Raymond James BUY $40.00
4 Aug 2026 Raymond James BUY $40.00
31 Jul 2026 LifeSci Capital BUY $44.00
31 Jul 2026 Morgan Stanley BUY $45.00

Discussion

No comments yet — be the first to weigh in on DYN.

Sign in to join the discussion.

Scroll to Top